DE000A3E5D64/ DE000A3E5D64 /
2024-05-21 12:36:12 PM | Chg. 0.000 | Volume | Bid1:02:29 PM | Ask1:02:29 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
45.200EUR | 0.00% | 0 Turnover: 0.000 |
45.060Bid Size: 750 | 45.320Ask Size: 800 | 5.34 bill.EUR | 2.45% | 21.74 |
GlobeNewswire
1:15 PM
FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
GlobeNewswire
1:10 PM
Carbon Streaming Announces Update on the Status of the Rimba Raya Verra Account and Concession Licen...
GlobeNewswire
1:07 PM
Stellantis to Participate in Bernstein 40th Annual Strategic Decisions Conference
GlobeNewswire
1:05 PM
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroi...
GlobeNewswire
1:00 PM
BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes
GlobeNewswire
1:00 PM
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
GlobeNewswire
1:00 PM
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the Americ...
GlobeNewswire
1:00 PM
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
GlobeNewswire
1:00 PM
Beyond BookSmart CEO Michael Delman and its Executive Function Coaching Clients to be Featured on AB...
GlobeNewswire
1:00 PM
Arctic Wolf 2024 Trends Report Reveals 70% of Businesses Targeted by Business Email Compromise (BEC)...
GlobeNewswire
1:00 PM
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
GlobeNewswire
1:00 PM
Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference
GlobeNewswire
1:00 PM
Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therap...